GuestLogix Inc (GXI)

Currency in CAD
0.095
0.000(0.00%)
Real-time Data·
Showing GuestLogix Inc historical data. For real-time data please try another search
Fair Value
Day's Range
0.0900.100
52 wk Range
0.0000.100
Key Statistics
Bid/Ask
0.09 / 0.10
Prev. Close
0.095
Open
0.09
Day's Range
0.09-0.1
52 wk Range
0-0
Volume
-
Average Volume (3m)
277.68K
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GXI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

GuestLogix Inc News & Analysis

Show more

GuestLogix Inc Company Profile

GuestLogix Inc. provides retail and payment technology solutions to the passenger travel industry. The company offers point-of-sale (POS) hardware solutions comprising mobile, POS device, and inflight entertainment systems; retail platform solutions; and payment processing technology, as well as OnTouch destination merchandising solutions. It also provides ancillary insights services, such as out-of-the-box reporting suites, enterprise reporting toolsets, and advanced analytics; and travel retail performance management services consisting of operational process development, outsourced retail management, and retail model development services. In addition, the company offers GuestPass Ticketing, a ticketing solution that enables travel operators to facilitate ticketing services across multiple access points; and t-Retail Platform, which provides destination-based content for travel operators to use in the booking path. It primarily serves customers in North America, Europe, South America, Africa, and Asia. The company is headquartered in Toronto, Canada.

Employees
126
Market
Canada

GuestLogix Inc Earnings Call Summary for Q4/2024

  • Vericelen reported 5.4% organic revenue growth and 6.4% increase in adjusted EBITDA to $425.54M in Q4
  • Biologics sector revenue share increased from 11% to 15%, strengthened by Vonjordi Pharma acquisition
  • Company forecasts 3-5% organic revenue growth for 2025, with adjusted EBITDA margin around 22%
  • Mid-term targets include 8-10% CAGR, margin expansion to 23-25%, and over 10% EPS growth
  • Analysts maintain Strong Buy consensus; potential risks include destocking effects and market softening in certain sectors
Last Updated: 26/02/2025, 11:50
Read Full Transcript

Compare GXI to Peers and Sector

Metrics to compare
GXI
Peers
Sector
Relationship
P/E Ratio
UnlockNaNNaNUnlock
PEG Ratio
UnlockNaNNaNUnlock
Price/Book
UnlockNaNNaNUnlock
Price / LTM Sales
UnlockNaNNaNUnlock
Upside (Analyst Target)
UnlockNaNNaNUnlock
Fair Value Upside
UnlockNaNNaNUnlock

Earnings

Latest Release
Mar 17, 2016
EPS / Forecast
-- / --
Revenue / Forecast
-- / 15.31M
EPS Revisions
Last 90 days

GXI Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.